Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1612
Publisher
MDPI AG
Online
2019-10-23
DOI
10.3390/cancers11101612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Failure to reabsorb the primary cilium induces cellular senescence
- (2019) Elizabeth P. Jeffries et al. FASEB JOURNAL
- Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
- (2019) Robert H. Berndsen et al. Cancers
- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation
- (2018) Gaëlle Marteil et al. Nature Communications
- Discovery of a novel inhibitor of kinesin-like protein KIFC1
- (2016) W. Zhang et al. BIOCHEMICAL JOURNAL
- Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma
- (2016) Shanthini M. Crusz et al. BMC Medicine
- High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells
- (2016) Thomas Horn et al. CANCER RESEARCH
- Optimization of drug combinations using Feedback System Control
- (2016) Patrycja Nowak-Sliwinska et al. Nature Protocols
- A CEP215–HSET complex links centrosomes with spindle poles and drives centrosome clustering in cancer
- (2016) Pavithra L. Chavali et al. Nature Communications
- Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers
- (2016) Sariah Liu et al. Oncotarget
- Chromothripsis: A New Mechanism for Rapid Karyotype Evolution
- (2015) Mitchell L. Leibowitz et al. Annual Review of Genetics
- Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives
- (2015) S.C. Joosten et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Centrosomes in spindle organization and chromosome segregation: a mechanistic view
- (2015) Patrick Meraldi CHROMOSOME RESEARCH
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- The Centrosome and Its Duplication Cycle
- (2015) Jingyan Fu et al. Cold Spring Harbor Perspectives in Biology
- A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer
- (2015) Joe R Delaney et al. Oncotarget
- In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
- (2015) M. Kashif et al. Scientific Reports
- Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
- (2015) Jie Ran et al. Scientific Reports
- A streamlined search technology for identification of synergistic drug combinations
- (2015) Andrea Weiss et al. Scientific Reports
- The chicken chorioallantoic membrane model in biology, medicine and bioengineering
- (2014) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Causes and consequences of centrosome abnormalities in cancer
- (2014) S. A. Godinho et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
- (2014) V Pannu et al. Cell Death & Disease
- Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1
- (2013) Jiaquan Wu et al. ACS Chemical Biology
- Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes
- (2013) Ciorsdaidh A. Watts et al. CHEMISTRY & BIOLOGY
- Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
- (2013) A.M. Molina et al. EUROPEAN JOURNAL OF CANCER
- The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells
- (2013) M-C Chen et al. Cell Death & Disease
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET
- (2012) Julia Kleylein-Sohn et al. JOURNAL OF CELL SCIENCE
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
- (2012) J R van Beijnum et al. ONCOGENE
- HDAC6 Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation in Renal Epithelial Cells
- (2012) Wei Liu et al. PLoS One
- Mechanism-independent method for predicting response to multidrug combinations in bacteria
- (2012) Kevin Wood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
- (2012) Y Adar et al. Cell Death & Disease
- The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
- (2011) M. J. LaBonte et al. CANCER RESEARCH
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries
- (2011) Erich A. Nigg et al. NATURE CELL BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- A mechanism linking extra centrosomes to chromosomal instability
- (2009) Neil J. Ganem et al. NATURE
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Regulation of endocytosis via the oxygen-sensing pathway
- (2009) Yi Wang et al. NATURE MEDICINE
- Multipolar Spindle Pole Coalescence Is a Major Source of Kinetochore Mis-Attachment and Chromosome Mis-Segregation in Cancer Cells
- (2009) William T. Silkworth et al. PLoS One
- Centrosome function in cancer: guilty or innocent?
- (2009) Deborah Zyss et al. TRENDS IN CELL BIOLOGY
- Genetics and epigenetics of renal cell cancer
- (2008) Marcella M.L. Baldewijns et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
- (2008) M. Kwon et al. GENES & DEVELOPMENT
- High-order combination effects and biological robustness
- (2008) Joseph Lehár et al. Molecular Systems Biology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started